Litigation Details for GILEAD SCIENCES, INC. v. SIGMAPHARM LABORATORIES, LLC. (D.N.J. 2015)
✉ Email this page to a colleague
GILEAD SCIENCES, INC. v. SIGMAPHARM LABORATORIES, LLC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-04-03 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-02-14 |
| Cause | 15:1126 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | Referred To | Joel Schneider | |
| Patents | RE42,462 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GILEAD SCIENCES, INC. v. SIGMAPHARM LABORATORIES, LLC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for GILEAD SCIENCES, INC. v. SIGMAPHARM LABORATORIES, LLC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-26 | 79 | terms of United States Reissue Patent No. RE42,462 (the “’462 Patent”). The Court has reviewed…1317-19. In a patent infringement suit, a court may properly interpret a patent to correct an obvious…reading the patent. The district court does not have authority to correct the patent in such circumstances…case is not appropriate. While a patent attorney or patent examiner may recognize that the Disputed…during the hectic process of patent prosecution where the focus is on a patent’s scope and validity and | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
